Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Infectious Disease Diagnostics Testing Market Size Likely To Evolve From 2025 Through 2034?
The market for diagnostics testing in the field of infectious diseases has seen considerable expansion during recent times, projected to increase from $38.52 billion in 2024 to reach $42.24 billion by 2025, reflecting a compound annual growth rate of 9.7%. This upward trajectory in the past era stems from several factors, including the emergence of significant disease episodes like SARS, Ebola, and Zika, heightened consciousness among both medical personnel and the public regarding the critical nature of swift identification and prophylaxis of contagious illnesses, an uptick in state-sponsored initiatives focusing on tracking, managing, and stopping disease spread, the acceleration of global movement and commerce which aids in transmitting infections, and escalating expenditures on healthcare, especially within developing nations.
Anticipating robust expansion, the market for infectious disease diagnostics testing is projected to reach a valuation of $60.71 billion by 2029, demonstrating a consistent compound annual growth rate (CAGR) of 9.5%; this upward trajectory is fueled by several key factors, including the persistent appearance of previously unseen disease agents like evolving influenza variants or novel coronaviruses, a broader movement towards tailored medical treatments and specific therapeutic approaches, an escalating need for diagnostic tools that provide results quickly and can be utilized immediately at the point of care, heightened concentration on systematic tracking of disease spread alongside systems designed for prompt identification, and greater investment in R&D efforts aimed at creating innovative diagnostic methods and biological markers.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
Which Drivers Are Shaping The Infectious Disease Diagnostics Testing Industry’s Market Share?
Anticipation is high for the infectious disease diagnostic testing market’s expansion, fueled primarily by an expected surge in respiratory infection occurrences. These infections impact the structures involved in breathing, spanning from the nasal passages and throat down to the airways and lungs. The heightened prevalence of these infections stems from several factors, including pathogen spread (both viral and bacterial) facilitated by proximity to affected persons, inadequate sanitation habits, densely populated environments, and shifts in climate across seasons. Accurately pinpointing bacteria and viruses within patient specimens makes infectious disease diagnostic testing a critical tool for managing and treating respiratory illnesses. To illustrate this impact, data from the Canadian Institute for Health Information, a Canadian nonprofit, showed a significant uptick in hospital admissions for acute upper respiratory infections, climbing 32 percent from 2,114 instances in 2022 to 2,797 in 2023 by February 2024; consequently, this increase in respiratory ailments serves as a major impetus for the growth trajectory of the infectious disease diagnostic testing sector.
What Are The Primary Types Of Segments Analyzed In The Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testingmarket covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Which Ongoing Trends Are Expected To Shape The Infectious Disease Diagnostics Testing Market Outlook?
To maintain their standing within the market landscape, leading firms engaged in the infectious disease diagnostic testing sector are concentrating efforts on creating cutting-edge solutions, exemplified by molecular diagnostics systems. These sophisticated platforms are engineered for the identification and analysis of genetic material, specifically DNA or RNA, sourced from biological specimens for diagnostic determination. As an illustration, in May of 2022, the American medical device corporation, Becton Dickinson and Company, introduced the BD COR System, which represents a completely automated, high-capacity molecular diagnostics platform for infectious diseases. This system streamlines and automates the entire molecular laboratory process, stretching from initial sample handling right through to the final diagnostic readouts, thereby removing the requirement for manual specimen arrangement and allowing laboratory personnel to dedicate their time to more critical responsibilities. Capable of analyzing as many as 1,700 samples and outputting findings inside a day, this apparatus provides both substantial processing volume and sophisticated genotyping capabilities for conditions including Human Papillomavirus and sexually transmitted infections.
Who Are The Core Companies Influencing The Infectious Disease Diagnostics Testing Market Landscape?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Infectious Disease Diagnostics Testing Market During The Forecast Period?
North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Infectious Disease Diagnostics Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2025, By The Business Research Company
Non Animal Alternatives Testing Global Market Report 2025
Pharmaceutical Sterility Testings Global Market Report 2025
Pcr And Realtime Pcr Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model